Monographie - Levofolinate calcium

Последно актуализиране :
19/11/2024

Levofolinate calcium

Химична структура

Търговско наименование

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

Calc Levof	Италия
Calcium levofolinat	Австрия
Elvorine	Белгия, Люксенбург, Мароко, Франция
Folaxin	Испания
Folinate EG	Белгия
Isovorin	Австрия, Великобритания, Гърция, Дания, Исландия, Испания, Финландия, Швеция
Levofolatino de calcio	Португалия
Levofolene	Италия

Библиография : Levofolinate calcium

	Вид	Публикация
3	Списание	Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
155	Списание	Trissel LA, Martinez JF, Xu QA. Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium. Am J Health-Syst Pharm 1995 ; 52: 710-715.
1520	Лаборатория	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1914	Лаборатория	Pemetrexed (Alimta®) - Summary of Product Characteristics Eli Lilly 2016
2130	Списание	Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J. Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique. Bull Cancer 1999 ; 86, 11: 946-954.
2181	Списание	Milano G, Renée N. Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique. Bull Cancer 1995 ; 82: 189-195.
2295	Лаборатория	Fosaprepitant (Emend®) - Summary of Product Characteristics Merck Sharp Dohme 2013
2361	Списание	Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L. Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags. J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
2531	Списание	Sanogo S, Silimbani P, Gaggeri R, Masini C. Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags. J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
3369	Лаборатория	Levofolinate de sodium Medac - Résumé des caractéristiques du produits MEDAC France 2011
3523	Лаборатория	Ceftriaxone (Rocephin®) - Summary of Product Characteristics. Roche 2018
3546	Лаборатория	Cefamandole Flavelab - Résumé des caractéristiques du produit Panpharma SA 2007
3619	Лаборатория	Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics Wockhardt 2016
3621	Лаборатория	Phosphate dipotassique - Résumé des caractéristiques du produit Renaudin 2008
3662	Лаборатория	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014
3753	Лаборатория	Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics Cubist Pharmaceuticals 2014
3838	Лаборатория	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3933	Лаборатория	Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit Teva Laboratoire 2015
4154	Лаборатория	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4720	Лаборатория	Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021. Paratek Pharmaceuticals 2021

Mentions Légales